Search Results 1291-1300 of 21369 for anti-TNF drugs

  1. Treatment of recurrent CDI: Examining the efficacy and safety of standardized live biotherapeutics as microbiota restoration therapies - Mayo Clinic

    Mayo Clinic gastroenterologist Sahil Khanna, M.B.B.S., M.S., discusses two microbiota restoration therapies for treatment of recurrent Clostridioides ...

  2. Advances in lung cancer immunotherapy and management of immune-mediated adverse events - Mayo Clinic

    Monotherapy, using the anti-PD-1 antibody pembrolizumab, is now Food and Drug Administration (FDA) approved for patients with stage IV non-small cell lung ...

  3. Ethionamide (Oral Route) Description and Brand Names - Mayo Clinic

    Ethionamide is used together with other medicines to treat tuberculosis (TB). Ethionamide belongs to the class of medicines called antibiotics and works to kill ...

  4. Leuprolide And Norethindrone (Intramuscular Route, Oral Route) Before Using - Mayo Clinic

    An alternative to this medication should be prescribed or you should stop breastfeeding while using this medicine. Drug Interactions. Although certain medicines ...

  5. Glycopyrrolate (Inhalation Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Lonhala Magnair; Seebri Neohaler. Descriptions.

  6. Telaprevir (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  7. Tofacitinib (Oral Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  8. Dactinomycin (Intravenous Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  9. Selinexor Treatment of Refractory Myeloma - Mayo Clinic

    ... anti-CD38 mAb, daratumumab. Refractory is defined as ≤ 25% response to therapy, or progression during therapy or progression within 60 days after ...

  10. Corticosteroid (Ophthalmic Route) Before Using - Mayo Clinic

    Ophthalmic corticosteroids have not been reported to cause problems in nursing babies. Drug Interactions. Although certain medicines should not be used together ...